Vystar Corp (VYST)

[gimmee greenbacks]

Doctors warn of delayed vaccine shipments ahead of flu season

https://www.cbs17.com/news/national-news/doctors-warn-of-delayed-vaccine-shipments-ahead-of-flu-season/


Vystar Contracts Med Air Solutions to White Label ViraTech Air Purification Systems And Distribute to Medical Housing Markets, Nursing Homes and Ecuador
GlobeNewswireJune 10, 2019, 8:30 AM EDT
WORCESTER, Mass., June 10, 2019 (GLOBE NEWSWIRE) -- Vystar® Corp. (VYST) and Competitive Edge Services LLC DBA Med Air Solutions (MAS) have signed an agreement whereby Med Air Solutions will white label Vystar’s air purification products that use patented Vystar ViraTech® technology as Med Air Solutions 400, and Med Air will have exclusive rights to market them to the nursing home and medical housing marketplaces, including hotels that are serving the hospital marketplace. Additionally, MAS will have exclusive rights to market the white labeled units throughout the country of Ecuador for one year with the option to extend the contract if certain sales goals are met.

“Med Air Solutions has already established itself as a trusted vendor for the medical housing marketplace,” stated Steve Rotman, Vystar CEO. “We believe engaging their distribution channels will help us penetrate this marketplace that is ideally suited for use of our air purification systems that destroys on first pass more than 99.97% of harmful airborne viruses and bacteria, and inactivates pathogens that cause measles, the common cold, MRSA (staph), whooping cough, TB, pneumonia and other antibiotic-resistant and viral infections. Additionally, Ecuador is a promising market where we currently have no presence, so this is an excellent opportunity to establish an initial foothold in South America without any additional expense to Vystar.”

“Catching a cold, or airborne virus can greatly imperil the fragile health of patients rehabilitating from a transplant, chemotherapy and other complicated procedures,” stated Michael Hedge, CEO of Med Air Solutions. “Also, nursing home residents can quickly spread illnesses due to the extensive use of common areas in these facilities. By offering the powerful pathogen-destroying ViraTech technology in the Med Air Solutions 400, we can reduce the risk of exposure to airborne viruses for nursing home residents and their caregivers while minimizing odors and bacteria to improve their quality of life. In addition, because the product has been certified as a Class 2 medical device by the FDA, the residents can be more at ease about engaging in social activities in common areas, particularly during cold and flu season.”



VYST